Biogen BIIB
NASDAQ BIIB
$219.88 -2.94 (-1.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biogen (BIIB) Land & Improvements (2009 - 2010)

Updated

Biogen (BIIB) recorded Land & Improvements of $107.6 million in Q4 2010, down 3.2% from $111.2 million a year earlier.

Analysis

Biogen (BIIB) Land & Improvements (2009 - 2010) Analysis & Trends

  • Across earlier years, Land & Improvements came in at $111.2 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Biogen 33.37 Bn 20.03 Bn 1.96 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 107.60 Mn
Dec 31, 2009 111.20 Mn
API Access

Biogen Land & Improvements API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=land-and-improvements&ticker=BIIB&period=max&api_key=YOUR_API_KEY